Fingerprint
Dive into the research topics of 'Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-emptive skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically